Company profile for InterveXion Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

InterveXion Therapeutics, LLC is a privately held, clinical-stage biotech company focused on developing innovative treatments for methamphetamine use disorder. Its lead candidate, devextinetug (IXT-m200), a monoclonal antibody that blocks methamphetamine from entering the central nervous system, is currently in Phase 2 trials for both methamphetamine use disorder and overdose. Backed entirely by NIDA grants, InterveXion has re...
InterveXion Therapeutics, LLC is a privately held, clinical-stage biotech company focused on developing innovative treatments for methamphetamine use disorder. Its lead candidate, devextinetug (IXT-m200), a monoclonal antibody that blocks methamphetamine from entering the central nervous system, is currently in Phase 2 trials for both methamphetamine use disorder and overdose. Backed entirely by NIDA grants, InterveXion has received FDA Fast Track designation and has reported positive Phase 2 proof-of-concept data. The pipeline also includes a vaccine and long-acting antibody therapies designed to reduce dosing frequency.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Little rock, Arkansas
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty